U.K. Plaintiffs Dismissed From Hemophilia Case

Law360, New York (May 7, 2007, 12:00 AM EDT) -- A federal appeals court panel has affirmed a lower court ruling that the United Kingdom, and not the United States, is the proper venue for a product liability suit brought by HIV-infected hemophiliacs against a handful of major drug companies.

The U.S. Court of Appeals for the Seventh Circuit on Friday dismissed the U.K. plaintiffs from a class action lawsuit against Baxter Healthcare Corp., Bayer Corp., Alpha Therapeutic Corp. and Armour Pharmaceutical Co., which together produce nearly all of the hemophilia medication in the U.S....
To view the full article, register now.